[1]
日本神経学会、「パーキンソン病診療ガイドライン」作成委員会(編), “パーキ
ンソン病診療ガイドライン2018,” 2018.
[2]
M. Yamawaki, M. Kusumi, H. Kowa, and K. Nakashima, “Changes in prevalence and
incidence of Parkinson’s disease in Japan during a quarter of a century,”
Neuroepidemiology, vol. 32, no. 4, pp. 263–269, 2009.
[3]
S. Lesage and A. Brice, “Parkinson’s disease: From monogenic forms to genetic
susceptibility factors,” Hum. Mol. Genet., vol. 18, no. R1, pp. 48–59, 2009.
[4]
H. Deng, P. Wang, and J. Jankovic, “The genetics of Parkinson disease,” Ageing Res.
Rev., vol. 42, no. September 2017, pp. 72–85, 2018.
[5]
D. Chang et al., “HHS Public Access,” vol. 49, no. 10, pp. 1511–1516, 2018.
[6]
A. J. Hughes et al., “A Clinicopathologic Study of 100 Cases of Parkinson’s Disease
Mini-Mental State examination6 and Diagnostic and Sta¬ tistical Manual of Mental
Disorders, Third Edition criteria. Dementia was defined as a Mini-Mental State
examination score of less than 20,” 2015.
[7]
J. Jankovic, “Parkinson’s disease: Clinical features and diagnosis,” J. Neurol.
Neurosurg. Psychiatry, vol. 79, no. 4, pp. 368–376, 2008.
[8]
R. B. Postuma et al., “MDS clinical diagnostic criteria for Parkinson’s disease,” Mov.
144
Disord., vol. 30, no. 12, pp. 1591–1601, 2015.
[9]
R. Djaldetti, I. Ziv, and E. Melamed, “The mystery of motor asymmetry in Parkinson’s
disease,” Lancet Neurol., vol. 5, no. 9, pp. 796–802, 2006.
[10]
S. Y. Lim and A. E. Lang, “The nonmotor symptoms of Parkinson’s disease-An
overview,” Mov. Disord., vol. 25, no. SUPPL. 1, 2010.
[11]
M. Coelho and J. J. Ferreira, “Late-stage Parkinson disease,” Nat. Rev. Neurol., vol. 8,
no. 8, pp. 435–442, 2012.
[12]
G. E. Alexander, M. R. DeLong, and P. L. Strick, “Parallel organization of
functionally segregated circuits linking basal ganglia and cortex.,” Annu. Rev.
Neurosci., vol. 9, no. 1, pp. 357–81, 1986.
[13]
G. E. Alexander and M. D. Crutcher, “Functional architecture of basal ganglia circuits:
neural substrates of parallel processing.,” Trends Neurosci., vol. 13, no. 7, pp. 266–71,
Jul. 1990.
[14]
M. R. DeLong and T. Wichmann, “Circuits and circuit disorders of the basal ganglia,”
Arch. Neurol., vol. 64, no. 1, pp. 20–24, 2007.
[15]
M. R. DeLong, “Primate models of movement disorders of basal ganglia origin,”
Trends Neurosci., vol. 13, no. 7, pp. 281–285, 1990.
[16]
C. Buhmann, V. Glauche, H. J. Stürenburg, M. Oechsner, C. Weiller, and C. Büchel,
“Pharmacologically modulated fMRI - Cortical responsiveness to levodopa in drug145
naive hemiparkinsonian patients,” Brain, vol. 126, no. 2, pp. 451–461, 2003.
[17]
C. Tessa et al., “Decreased and increased cortical activation coexist in de novo
Parkinson’s disease,” Exp. Neurol., vol. 224, no. 1, pp. 299–306, 2010.
[18]
H. Yu, D. Sternad, D. M. Corcos, and D. E. Vaillancourt, “Role of hyperactive
cerebellum and motor cortex in Parkinson’s disease.,” Neuroimage, vol. 35, no. 1, pp.
222–33, Mar. 2007.
[19]
G. Deuschl et al., “A Randomized Trial of Deep-Brain Stimulation for Parkinson’s
Disease,” N. Engl. J. Med., vol. 355, no. 9, pp. 896–908, 2006.
[20]
J. M. Bronstein et al., “Deep brain stimulation for Parkinson disease an expert
consensus and review of key issues,” Arch. Neurol., vol. 68, no. 2, pp. 165–171, 2011.
[21]
A. Horn et al., “Deep brain stimulation induced normalization of the human functional
connectome in Parkinson’s disease,” Brain, vol. 142, no. 10, pp. 3129–3143, 2019.
[22]
H. Mure et al., “Improved sequence learning with subthalamic nucleus deep brain
stimulation: Evidence for treatment-specific network modulation,” J. Neurosci., vol.
32, no. 8, pp. 2804–2813, 2012.
[23]
G. Goldberg, “Supplementary motor area structure and function: Review and
hypotheses,” Behav. Brain Sci., vol. 8, no. 4, pp. 567–588, 1985.
[24]
J. Tanji, “New concepts of the supplementary motor area,” Curr. Opin. Neurobiol.,
vol. 6, no. 6, pp. 782–787, 1996.
146
[25]
P. Nachev, C. Kennard, and M. Husain, “Functional role of the supplementary and presupplementary motor areas,” Nat. Rev. Neurosci., vol. 9, no. 11, pp. 856–869, 2008.
[26]
D. Athauda and T. Foltynie, “The ongoing pursuit of neuroprotective therapies in
Parkinson disease,” Nat. Rev. Neurol., vol. 11, no. 1, pp. 25–40, 2015.
[27]
J. G. Nutt, “Pharmacokinetics and pharmacodynamics of levodopa,” Mov. Disord., vol.
23, no. SUPPL. 3, pp. 580–584, 2008.
[28]
A. Antonini, E. Tolosa, Y. Mizuno, M. Yamamoto, and W. H. Poewe, “A reassessment
of risks and benefits of dopamine agonists in Parkinson’s disease,” Lancet Neurol.,
vol. 8, no. 10, pp. 929–937, 2009.
[29]
S. P. Bratsos, D. Karponis, and S. N. Saleh, “Efficacy and Safety of Deep Brain
Stimulation in the Treatment of Parkinson’s Disease: A Systematic Review and Metaanalysis of Randomized Controlled Trials,” Cureus, vol. 10, no. 10, 2018.
[30]
K. A. Follett et al., “Pallidal versus Subthalamic Deep-Brain Stimulation for
Parkinson’s Disease,” N. Engl. J. Med., vol. 362, no. 22, pp. 2077–2091, 2010.
[31]
F. M. Weaver et al., “Randomized trial of deep brain stimulation for Parkinson
disease: Thirty-six-month outcomes,” Neurology, vol. 79, no. 1, pp. 55–65, 2012.
[32]
A. A. Othman et al., “Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus
Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with
Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety,” Clin.
147
Pharmacokinet., vol. 54, no. 9, pp. 975–984, 2015.
[33]
D. Nyholm et al., “Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa
following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced
parkinson’s disease patients,” AAPS J., vol. 15, no. 2, pp. 316–323, 2013.
[34]
K. Wirdefeldt, P. Odin, and D. Nyholm, “Levodopa–Carbidopa Intestinal Gel in
Patients with Parkinson’s Disease: A Systematic Review,” CNS Drugs, vol. 30, no. 5,
pp. 381–404, 2016.
[35]
U. Ziemann et al., “Consensus: Motor cortex plasticity protocols,” Brain Stimul., vol.
1, no. 3, pp. 164–182, 2008.
[36]
S. Rossi et al., “Safety, ethical considerations, and application guidelines for the use of
transcranial magnetic stimulation in clinical practice and research,” Clin.
Neurophysiol., vol. 120, no. 12, pp. 2008–2039, 2009.
[37]
A. Zanjani, K. K. Zakzanis, Z. J. Daskalakis, and R. Chen, “Repetitive transcranial
magnetic stimulation of the primary motor cortex in the treatment of motor signs in
Parkinson’s disease: A quantitative review of the literature,” Mov. Disord., vol. 30, no.
6, pp. 750–758, 2015.
[38]
Y. H. Chou, P. T. Hickey, M. Sundman, A. W. Song, and N. K. Chen, “Effects of
repetitive transcranial magnetic stimulation on motor symptoms in parkinson disease:
A systematic review and meta-analysis,” JAMA Neurol., vol. 72, no. 4, pp. 432–440,
148
2015.
[39]
C. L. Chung and M. K. Y. Mak, “Effect of Repetitive Transcranial Magnetic
Stimulation on Physical Function and Motor Signs in Parkinson’s Disease: A
Systematic Review and Meta-Analysis,” Brain Stimul., vol. 9, no. 4, pp. 475–487,
2016.
[40]
J. P. Lefaucheur et al., “Evidence-based guidelines on the therapeutic use of repetitive
transcranial magnetic stimulation (rTMS),” Clin. Neurophysiol., vol. 125, no. 11, pp.
2150–2206, 2014.
[41]
J. P. Lefaucheur et al., “Evidence-based guidelines on the therapeutic use of repetitive
transcranial magnetic stimulation (rTMS): An update (2014–2018),” Clin.
Neurophysiol., vol. 131, no. 2, pp. 474–528, 2020.
[42]
M. Hamada et al., “High-frequency rTMS over the supplementary motor area for
treatment of Parkinson’s disease,” Mov. Disord., vol. 23, no. 11, pp. 1524–1531, 2008.
[43]
Y. Shirota, H. Ohtsu, M. Hamada, H. Enomoto, and Y. Ugawa, “Supplementary motor
area stimulation for Parkinson disease: A randomized controlled study,” Neurology,
vol. 80, no. 15, pp. 1400–1405, 2013.
[44]
濱田雅, “パーキンソン病に対する 磁気刺激治療,” Jpn J Rehabil Med, vol. 56, no.
1, pp. 44–47, 2019.
[45]
C. Ramaker, J. Marinus, A. M. Stiggelbout, and B. J. van Hilten, “Systematic
149
evaluation of rating scales for impairment and disability in Parkinson’s disease,” Mov.
Disord., vol. 17, no. 5, pp. 867–876, 2002.
[46]
C. G. Goetz et al., “Movement Disorder Society-Sponsored Revision of the Unified
Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric
testing results,” Mov. Disord., vol. 23, no. 15, pp. 2129–2170, 2008.
[47]
C. G. Goetz, G. T. Stebbins, T. A. Chmura, S. Fahn, W. Poewe, and C. M. Tanner,
“Teaching program for the Movement Disorder Society-sponsored revision of the
Unified Parkinson’s Disease Rating Scale: (MDS-UPDRS),” Mov. Disord., vol. 25, no.
9, pp. 1190–1194, 2010.
[48]
Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease,
“The Unified Parkinson’s Disease Rating Scale (UPDRS): status and
recommendations.,” Mov. Disord., vol. 18, no. 7, pp. 738–50, Jul. 2003.
[49]
M. Bologna et al., “Bradykinesia in early and advanced Parkinson’s disease,” J.
Neurol. Sci., vol. 369, pp. 286–291, 2016.
[50]
A. J. Espay, D. E. Beaton, F. Morgante, C. A. Gunraj, A. E. Lang, and R. Chen,
“Impairments of speed and amplitude of movement in Parkinson’s disease: A pilot
study,” Mov. Disord., vol. 24, no. 7, pp. 1001–1008, 2009.
[51]
A. J. Espay et al., “Differential response of speed, amplitude, and rhythm to
dopaminergic medications in Parkinson’s disease.,” Mov. Disord., vol. 26, no. 14, pp.
150
2504–8, Dec. 2011.
[52]
H. Ling, L. A. Massey, A. J. Lees, P. Brown, and B. L. Day, “Hypokinesia without
decrement distinguishes progressive supranuclear palsy from Parkinson’s disease,”
Brain, vol. 135, no. 4, pp. 1141–1153, 2012.
[53]
M. Bologna et al., “Neurophysiological correlates of bradykinesia in Parkinson’s
disease,” Brain, vol. 141, no. 8, pp. 2432–2444, 2018.
[54]
M. Hamada, Y. Ugawa, and S. Tsuji, “High-frequency rTMS over the supplementary
motor area improves bradykinesia in Parkinson’s disease: Subanalysis of double-blind
sham-controlled study,” J. Neurol. Sci., vol. 287, no. 1–2, pp. 143–146, 2009.
[55]
M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality.,”
Neurology, vol. 17, no. 5, pp. 427–42, May 1967.
[56]
K. Kashihara et al., “Official Japanese Version of the International Parkinson and
Movement Disorder Society–Unified Parkinson’s Disease Rating Scale: Validation
Against the Original English Version,” Mov. Disord. Clin. Pract., vol. 1, no. 3, pp.
200–212, 2014.
[57]
D. A. Heldman et al., “The modified bradykinesia rating scale for Parkinson’s disease:
reliability and comparison with kinematic measures.,” Mov. Disord., vol. 26, no. 10,
pp. 1859–63, Aug. 2011.
[58]
T. Endo, M. Yokoe, H. Fujimura, and S. Sako, “Novel Methods to Evaluate Symptoms
151
in Parkinson’s Disease – Rigidity and Finger Tappin,” Diagnostics Rehabil. Park. Dis.,
2011.
[59]
W. P. Teo, J. P. Rodrigues, F. L. Mastaglia, and G. W. Thickbroom, “Comparing
kinematic changes between a finger-tapping task and unconstrained finger flexionextension task in patients with Parkinson’s disease,” Exp. Brain Res., vol. 227, no. 3,
pp. 323–331, 2013.
[60]
E. Růžička, R. Krupička, K. Zárubová, J. Rusz, R. Jech, and Z. Szabó, “Tests of
manual dexterity and speed in Parkinson’s disease: Not all measure the same,” Park.
Relat. Disord., vol. 28, pp. 118–123, 2016.
[61]
W. R. Gibb and A. J. Lees, “The relevance of the Lewy body to the pathogenesis of
idiopathic Parkinson’s disease.,” J. Neurol. Neurosurg. Psychiatry, vol. 51, no. 6, pp.
745–52, Jun. 1988.
[62]
R. Agostino, A. Berardelli, A. Currà, N. Accornero, and M. Manfredi, “Clinical
impairment of sequential finger movements in Parkinson’s disease,” Mov. Disord., vol.
13, no. 3, pp. 418–421, 1998.
[63]
R. Agostino, A. Currà, M. Giovannelli, N. Modugno, M. Manfredi, and A. Berardelli,
“Impairment of individual finger movements in Parkinson’s disease,” Mov. Disord.,
vol. 18, no. 5, pp. 560–565, 2003.
[64]
R. C. Oldfield, “The assessment and analysis of handedness: the Edinburgh
152
inventory,” Neuropsychologia, vol. 9, no. 1, pp. 97–113, 1971.
[65]
G. T. Stebbins, C. G. Goetz, D. J. Burn, J. Jankovic, T. K. Khoo, and B. C. Tilley,
“How to identify tremor dominant and postural instability/gait difficulty groups with
the movement disorder society unified Parkinson’s disease rating scale: Comparison
with the unified Parkinson’s disease rating scale,” Mov. Disord., vol. 28, no. 5, pp.
668–670, 2013.
[66]
J. C. van den Noort et al., “Quantification of Hand Motor Symptoms in Parkinson’s
Disease: A Proof-of-Principle Study Using Inertial and Force Sensors,” Ann. Biomed.
Eng., vol. 45, no. 10, pp. 2423–2436, 2017.
[67]
J. Rusz et al., “Comparative analysis of speech impairment and upper limb motor
dysfunction in Parkinson’s disease,” J. Neural Transm., vol. 124, no. 4, pp. 463–470,
2017.
[68]
J. Jankovic et al., “Variable expression of Parkinson’s disease: a base-line analysis of
the DATATOP cohort. The Parkinson Study Group.,” Neurology, vol. 40, no. 10, pp.
1529–34, Oct. 1990.
[69]
A. T. Barker, R. Jalinous, and I. L. Freeston, “Wireless light-weight IEC 61850 based
loss of mains protection for smart grid,” Lancet, vol. 325, no. 8437, pp. 1106–1107,
1985.
[70]
R. Chen et al., “Depression of motor cortex excitability by low-frequency transcranial
153
magnetic stimulation,” Neurology, vol. 48, no. 5, pp. 1398–1403, 1997.
[71]
A. Pascual-Leone, J. Valls-Solé, J. P. Brasil-Neto, A. Cammarota, J. Grafman, and M.
Hallett, “Akinesia in Parkinson’s disease. II. Effects of subthreshold repetitive
transcranial motor cortex stimulation.,” Neurology, vol. 44, no. 5, pp. 892–8, May
1994.
[72]
A. Berardelli et al., “Facilitation of muscle evoked responses after repetitive cortical
stimulation in man,” Exp. Brain Res., vol. 122, no. 1, pp. 79–84, 1998.
[73]
F. Maeda, J. P. Keenan, J. M. Tormos, H. Topka, and A. Pascual-Leone,
“Interindividual variability of the modulatory effects of repetitive transcranial
magnetic stimulation on cortical excitability,” Exp. Brain Res., vol. 133, no. 4, pp.
425–430, 2000.
[74]
P. B. Fitzgerald, S. Fountain, and Z. J. Daskalakis, “A comprehensive review of the
effects of rTMS on motor cortical excitability and inhibition,” Clin. Neurophysiol., vol.
117, no. 12, pp. 2584–2596, 2006.
[75]
Y. Z. Huang, M. J. Edwards, E. Rounis, K. P. Bhatia, and J. C. Rothwell, “Theta burst
stimulation of the human motor cortex,” Neuron, vol. 45, no. 2, pp. 201–206, 2005.
[76]
G. W. Thickbroom, M. L. Byrnes, D. J. Edwards, and F. L. Mastaglia, “Repetitive
paired-pulse TMS at I-wave periodicity markedly increases corticospinal excitability:
A new technique for modulating synaptic plasticity,” Clin. Neurophysiol., vol. 117, no.
154
1, pp. 61–66, 2006.
[77]
M. Hamada et al., “Bidirectional long-term motor cortical plasticity and metaplasticity
induced by quadripulse transcranial magnetic stimulation,” J. Physiol., vol. 586, no.
16, pp. 3927–3947, 2008.
[78]
M. Hamada and Y. Ugawa, “Quadripulse stimulation - A new patterned rTMS,”
Restor. Neurol. Neurosci., vol. 28, no. 4, pp. 419–424, 2010.
[79]
M. Hamada, N. Murase, A. Hasan, M. Balaratnam, and J. C. Rothwell, “The role of
interneuron networks in driving human motor cortical plasticity,” Cereb. Cortex, vol.
23, no. 7, pp. 1593–1605, 2013.
[80]
K. Nakamura et al., “Variability in Response to Quadripulse Stimulation of the Motor
Cortex,” Brain Stimul., vol. 9, no. 6, pp. 859–866, 2016.
[81]
R. Hanajima et al., “The effect of age on the homotopic motor cortical long-term
potentiation-like effect induced by quadripulse stimulation,” Exp. Brain Res., vol. 235,
no. 7, pp. 2103–2108, 2017.
[82]
A. Tiksnadi, T. Murakami, W. Wiratman, H. Matsumoto, and Y. Ugawa, “Direct
Comparison of Efficacy of the Motor Cortical Plasticity Induction and the
Interindividual Variability between TBS and QPS,” Brain Stimul., vol. 13, no. 6, pp.
1824–1833, 2020.
[83]
F. Fregni, D. K. Simon, A. Wu, and A. Pascual-Leone, “Non-invasive brain
155
stimulation for Parkinson’s disease: A systematic review and meta-analysis of the
literature,” J. Neurol. Neurosurg. Psychiatry, vol. 76, no. 12, pp. 1614–1623, 2005.
[84]
M. Yokoe et al., “The optimal stimulation site for high-frequency repetitive
transcranial magnetic stimulation in Parkinson’s disease: A double-blind crossover
pilot study,” J. Clin. Neurosci., vol. 47, pp. 72–78, 2018.
[85]
A. R. Mitz and S. P. Wise, “The somatotopic organization of the supplementary motor
area: Intracortical microstimulation mapping,” J. Neurosci., vol. 7, no. 4, pp. 1010–
1021, 1987.
[86]
M. Matelli, G. Luppino, and G. Rizzolatti, “Architecture of superior and mesial area 6
and the adjacent cingulate cortex in the macaque monkey,” J. Comp. Neurol., vol. 311,
no. 4, pp. 445–462, 1991.
[87]
I. Fried et al., “Functional organization of human supplementary motor cortex studies
by electrical stimulation,” J. Neurosci., vol. 11, no. 11, pp. 3656–3666, 1991.
[88]
G. Luppino, M. Matelli, R. Camarda, and G. Rizzolatti, “Corticocortical connections
of area F3 (SMA‐proper) and area F6 (pre‐SMA) in the macaque monkey,” J. Comp.
Neurol., vol. 338, no. 1, pp. 114–140, 1993.
[89]
R. P. Dum and P. L. Strick, “Frontal lobe inputs to the digit representations of the
motor areas on the lateral surface of the hemisphere,” J. Neurosci., vol. 25, no. 6, pp.
1375–1386, 2005.
156
[90]
N. Arai, M. K. Lu, Y. Ugawa, and U. Ziemann, “Effective connectivity between
human supplementary motor area and primary motor cortex: A paired-coil TMS
study,” Exp. Brain Res., vol. 220, no. 1, pp. 79–87, 2012.
[91]
P. E. Green, M. C. Ridding, K. D. Hill, J. G. Semmler, P. D. Drummond, and A. M.
Vallence, “Supplementary motor area—primary motor cortex facilitation in younger
but not older adults,” Neurobiol. Aging, vol. 64, pp. 85–91, 2018.
[92]
G. Koch et al., “rTMS of supplementary motor area modulates therapy-induced
dyskinesias in Parkinson disease,” Neurology, vol. 65, no. 4, pp. 623–625, 2005.
[93]
L. Brusa et al., “Low frequency rTMS of the SMA transiently ameliorates peak-dose
LID in Parkinson’s disease,” Clin. Neurophysiol., vol. 117, no. 9, pp. 1917–1921,
2006.
[94]
Y. H. Kim et al., “Repetitive transcranial magnetic stimulation-induced corticomotor
excitability and associated motor skill acquisition in chronic stroke,” Stroke, vol. 37,
no. 6, pp. 1471–1476, 2006.
[95]
V. López-Alonso, B. Cheeran, D. Río-Rodríguez, and M. Fernández-Del-Olmo, “Interindividual variability in response to non-invasive brain stimulation paradigms,” Brain
Stimul., vol. 7, no. 3, pp. 372–380, 2014.
[96]
J. F. M. Müller-Dahlhaus, Y. Orekhov, Y. Liu, and U. Ziemann, “Interindividual
variability and age-dependency of motor cortical plasticity induced by paired
157
associative stimulation,” Exp. Brain Res., vol. 187, no. 3, pp. 467–475, 2008.
[97]
M. C. Ridding and U. Ziemann, “Determinants of the induction of cortical plasticity by
non-invasive brain stimulation in healthy subjects,” J. Physiol., vol. 588, no. 13, pp.
2291–2304, 2010.
[98]
S. Kadowaki, H. Enomoto, T. Murakami, S. Nakatani-Enomoto, S. Kobayashi, and Y.
Ugawa, “Influence of phasic muscle contraction upon the quadripulse stimulation
(QPS) aftereffects,” Clin. Neurophysiol., vol. 127, no. 2, pp. 1568–1573, 2016.
[99]
S. Simeoni et al., “Effects of Quadripulse Stimulation on Human Motor Cortex
Excitability: A Replication Study.,” Brain Stimul., vol. 9, no. 1, pp. 148–50, 2016.
[100] S. Rossi et al., “Safety and recommendations for TMS use in healthy subjects and
patient populations, with updates on training, ethical and regulatory issues: Expert
Guidelines,” Clin. Neurophysiol., no. xxxx, 2020.
[101] P. M. Rossini et al., “Non-invasive electrical and magnetic stimulation of the brain,
spinal cord, roots and peripheral nerves: Basic principles and procedures for routine
clinical and research application: An updated report from an I.F.C.N. Committee,”
Clin. Neurophysiol., vol. 91, no. 2, pp. 79–92, 1994.
[102] K. Matsunaga, A. Maruyama, T. Fujiwara, R. Nakanishi, S. Tsuji, and J. C. Rothwell,
“Increased corticospinal excitability after 5 Hz rTMS over the human supplementary
motor area,” J. Physiol., vol. 562, no. 1, pp. 295–306, 2005.
158
[103] Y. Terao et al., “Interhemispheric transmission of visuomotor information for motor
implementation,” Cereb. Cortex, vol. 15, no. 7, pp. 1025–1036, 2005.
[104] Y. Terao et al., “Modifying the cortical processing for motor preparation by repetitive
transcranial magnetic stimulation,” J. Cogn. Neurosci., vol. 19, no. 9, pp. 1556–1573,
2007.
[105] M. C. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Fervert A, Wroe
S, Asselman P, “Corticocortical inhibition in human motor cortex.,” J. Physiol., vol.
471, pp. 501–519, 1993.
[106] V. Di Lazzaro et al., “Direct demonstration of the effect of lorazepam on the
excitability of the human motor cortex,” Clin. Neurophysiol., vol. 111, no. 5, pp. 794–
799, 2000.
[107] T. V. Ilić, F. Meintzschel, U. Cleff, D. Ruge, K. R. Kessler, and U. Ziemann, “Shortinterval paired-pulse inhibition and facilitation of human motor cortex: The dimension
of stimulus intensity,” J. Physiol., vol. 545, no. 1, pp. 153–167, 2002.
[108] U. Ziemann, R. Chen, L. G. Cohen, and M. Hallett, “Dextromethorphan decreases the
excitability of the human motor cortex,” Neurology, vol. 51, no. 5, pp. 1320–1324,
1998.
[109] R. Chen et al., “The clinical diagnostic utility of transcranial magnetic stimulation:
Report of an IFCN committee,” Clin. Neurophysiol., vol. 119, no. 3, pp. 504–532,
159
2008.
[110] V. Rizzo et al., “Shaping the excitability of human motor cortex with premotor
rTMS,” J. Physiol., vol. 554, no. 2, pp. 483–495, 2004.
[111] F. Gilio, V. Rizzo, H. R. Siebner, and J. C. Rothwell, “Effects on the right motor handarea excitability produced by low-frequency rTMS over human contralateral
homologous cortex,” J. Physiol., vol. 551, no. 2, pp. 563–573, 2003.
[112] N. Arai et al., “State-dependent and timing-dependent bidirectional associative
plasticity in the human SMA-M1 network,” J. Neurosci., vol. 31, no. 43, pp. 15376–
15383, 2011.
[113] M. Hamada et al., “Primary motor cortical metaplasticity induced by priming over the
supplementary motor area,” J. Physiol., vol. 587, no. 20, pp. 4845–4862, 2009.
[114] Y. Shirota, R. Hanajima, S. Ohminami, R. Tsutsumi, Y. Ugawa, and Y. Terao,
“Supplementary motor area plays a causal role in automatic inhibition of motor
responses,” Brain Stimul., vol. 12, no. 4, pp. 1020–1026, 2019.
[115] T. Shimizu et al., “Plasticity induction in the pre-supplementary motor area (pre-SMA)
and SMA-proper differentially affects visuomotor sequence learning,” Brain Stimul.,
vol. 13, no. 1, pp. 229–238, 2020.
[116] O. Rascol et al., “Supplementary and Primary Sensory Motor Area Activity in
Parkinson’s Disease: Regional Cerebral Blood Flow Changes During Finger
160
Movements and Effects of Apomorphine,” Arch. Neurol., vol. 49, no. 2, pp. 144–148,
1992.
[117] B. Haslinger et al., “Event-related functional magnetic resonance imaging in
Parkinson’s disease before and after levodopa,” Brain, vol. 124, no. 3, pp. 558–570,
2001.
[118] T. Eckert, T. Peschel, H. J. Heinze, and M. Rotte, “Increased pre-SMA activation in
early PD patients during simple self-initiated hand movements,” J. Neurol., vol. 253,
no. 2, pp. 199–207, 2006.
[119] E. D. Playford, I. H. Jenkins, R. E. Passingham, J. Nutt, R. S. J. Frackowiak, and D. J.
Brooks, “Impaired mesial frontal and putamen activation in Parkinson’s disease: A
positron emission tomography study,” Ann. Neurol., vol. 32, no. 2, pp. 151–161, 1992.
[120] W. Strube, T. Bunse, B. Malchow, and A. Hasan, “Efficacy and interindividual
variability in motor-cortex plasticity following anodal tDCS and paired-associative
stimulation,” Neural Plast., vol. 2015, 2015.
[121] B. Cheeran et al., “A common polymorphism in the brain-derived neurotrophic factor
gene ( BDNF) modulates human cortical plasticity and the response to rTMS,” J.
Physiol., vol. 586, no. 23, pp. 5717–5725, 2008.
[122] N. Arai et al., “Differences in after-effect between monophasic and biphasic highfrequency rTMS of the human motor cortex,” Clin. Neurophysiol., vol. 118, no. 10, pp.
161
2227–2233, 2007.
[123] K. Nakamura et al., “Variability in Response to Quadripulse Stimulation of the Motor
Cortex,” Brain Stimul., vol. 9, no. 6, pp. 859–866, 2016.
[124] T. D. Sanger, R. R. Garg, and R. Chen, “Interactions between two different inhibitory
systems in the human motor cortex,” J. Physiol., vol. 530, no. 2, pp. 307–317, 2001.
[125] L. Roshan, G. O. Paradiso, and R. Chen, “Two phases of short-interval intracortical
inhibition,” Exp. Brain Res., vol. 151, no. 3, pp. 330–337, 2003.
[126] Z. J. Daskalakis, G. O. Paradiso, B. K. Christensen, P. B. Fitzgerald, C. Gunraj, and R.
Chen, “Exploring the connectivity between the cerebellum and motor cortex in
humans,” J. Physiol., vol. 557, no. 2, pp. 689–700, 2004.
[127] M. I. Garry and R. H. S. Thomson, “The effect of test TMS intensity on short-interval
intracortical inhibition in different excitability states,” Exp. Brain Res., vol. 193, no. 2,
pp. 267–274, 2009.
[128] C. Gerloff, B. Corwell, R. Chen, M. Hallett, and L. G. Cohen, “Stimulation over the
human supplementary motor area interferes with the organization of future elements in
complex motor sequences,” Brain, vol. 120, no. 9, pp. 1587–1602, 1997.
[129] M. Dafotakis, C. Grefkes, L. Wang, G. R. Fink, and D. A. Nowak, “The effects of 1
Hz rTMS over the hand area of M1 on movement kinematics of the ipsilateral hand,”
J. Neural Transm., vol. 115, no. 9, pp. 1269–1274, 2008.
162
[130] L. Jäncke, H. Steinmetz, S. Benilow, and U. Ziemann, “Slowing fastest finger
movements of the dominant hand with low-frequency rTMS of the hand area of the
primary motor cortex,” Exp. Brain Res., vol. 155, no. 2, pp. 196–203, 2004.
163
...
論文の公開元へ
